Petros Pharmaceuticals, Inc. (PTPI) › EBITDAPetros Pharmaceuticals, Inc. (PTPI): EBITDAOperating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.-$1.80MYear ended 2024-12-312020-12-31: -$10.62M2021-12-31: -$11.17M2022-12-31: -$14.32M2023-12-31: -$10.33M2024-12-31: -$1.80M-$1.80M2020-12-31 EBITDA (USD) 2024-12-31Period endedEBITDAChange YoYSource filing2024-12-31-$1.80Mn/m2026-04-15, From 2024-01-012023-12-31-$10.33Mn/m2025-03-31, From 2023-01-012022-12-31-$14.32Mn/m2024-04-01, From 2022-01-012021-12-31-$11.17Mn/m2023-03-31, From 2021-01-012020-12-31-$10.62Mn/a2022-03-31, From 2020-01-01Other metrics: RevenueCost of RevenueGross ProfitR&D ExpenseOperating IncomeDepreciation & AmortizationNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresFree Cash FlowShares OutstandingWeighted Average Diluted SharesEPS (Basic)